Correspondence | Published:

The role of a bioresource research impact factor as an incentive to share human bioresources

Nature Genetics volume 43, pages 503504 (2011) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Lancet 377, 2011–2018 (2011).

  2. 2.

    Anonymous. Nat. Med. 17, 137 (2011).

  3. 3.

    Nat. Genet. 34, 25–26 (2003).

  4. 4.

    & J. Am. Med. Assoc. 299, 2316–2318 (2008).

  5. 5.

    & Nat. Genet. 42, 919 (2010).

  6. 6.

    , , , & Nat. Rev. Genet. 10, 331–335 (2009).

  7. 7.

    Toronto International Data Release Workshop Authors et al. Nature 461, 168–170 (2009).

Download references

Acknowledgements

The BRIF workshop was funded by the European Community's Seventh Framework project 'Biobanking and Biomolecular Resources Research Infrastructure' (BBMRI), grant agreement 212111. The BRIF research also received funds from FP7 collaborative projects GEN2PHEN (Genotype-to-Phenotype Databases: A Holistic Solution), grant agreement 200754 and BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union) and grant agreement 261433. In addition to thanking all the BRIF workshop participants for their active contribution, we wish to thank E. Bravo, A. Garcia-Montero, M. Morente, C. Neylon, C. Schröder, V. Tate, S. Wallace and M. Yuille for having provided input in the global debate through the BRIF online forum and for discussion.

Author information

Affiliations

  1. Inserm, UMR1027, Epidemiology and Analyses in Public Health, Toulouse, France.

    • Anne Cambon-Thomsen
    •  & Laurence Mabile
  2. Université de Toulouse, Université Paul Sabatier, Toulouse III, UMR 1027, Toulouse, France.

    • Anne Cambon-Thomsen
    •  & Laurence Mabile
  3. Department of Genetics, University of Leicester, Leicester, UK.

    • Gudmundur A Thorisson
  4. Inserm, UMR1027, Epidemiology and Analyses in Public Health, Toulouse, France.

    • Sandrine Andrieu
    • , Anne Cambon-Thomsen
    • , Laurence Mabile
    • , Emmanuelle Rial-Sebbag
    •  & Mogens Thomsen
  5. Université de Toulouse, Université Paul Sabatier, Toulouse III, UMR 1027, Toulouse, France.

    • Sandrine Andrieu
    • , Anne Cambon-Thomsen
    • , Laurence Mabile
    • , Emmanuelle Rial-Sebbag
    •  & Mogens Thomsen
  6. Center for Genomic Regulation, Barcelona, Spain.

    • Gabrielle Bertier
  7. University of Amsterdam, Department of Philosophy, Amsterdam, The Netherlands.

    • Martin Boeckhout
  8. Australian Breast Cancer Tissue Bank, University of Sydney, New South Wales, Sydney, Australia.

    • Jane Carpenter
  9. Inserm, Public Health Institute, Paris, France.

    • Georges Dagher
  10. Department of Genetics, University of Leicester, Leicester, UK.

    • Raymond Dalgleish
    •  & Gudmundur A Thorisson
  11. P3G, Montreal, Quebec, Canada.

    • Mylène Deschênes
  12. 3C-R, Toulouse, France.

    • Jeanne Hélène di Donato
  13. Laboratorio Diagnosi Pre-Postnatale Malattie Metaboliche, Istituto G. Gaslini, G. Gaslini Institute, Genova, Italy.

    • Mirella Filocamo
  14. Inserm U1018, Centre for Research in Epidemiology and Population Health, Villejuif, France.

    • Marcel Goldberg
    • , Francine Kauffmann
    •  & Marie Zins
  15. Versailles-Saint Quentin University, UMRS 1018, Versailles, France.

    • Marcel Goldberg
    •  & Marie Zins
  16. European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB), Aix en Provence, France.

    • Robert Hewitt
  17. Laboratory of Clinical and Experimental Pathology & Human Biobank, Pasteur Hospital, University of Nice Sophia, Nice, France.

    • Paul Hofman
  18. Paris Sud University, UMRS 1018, Villejuif, France.

    • Francine Kauffmann
  19. Estonian Genome Center, University of Tartu, Tartu, Estonia.

    • Liis Leitsalu
    •  & Andres Metspalu
  20. Laboratorio ImmunoBiología Molecular, Spanish HIV HGM BioBank, Madrid, Spain.

    • Irene Lomba
  21. Department of Medical Genetics, University of Pécs, Pécs, Hungary.

    • Bela Melegh
  22. Estonian Genome Center, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.

    • Andres Metspalu
  23. Estonian Biocentre, Tartu, Estonia.

    • Andres Metspalu
  24. Biobusiness Consulting, Inc., Lowell, Massachusetts, USA.

    • Lisa Miranda
  25. Istituto Superiore di Sanita, Rome, Italy.

    • Federica Napolitani
  26. World Health Organization, Department of Health Statistics & Informatics, Geneva, Switzerland.

    • Mikkel Z Oestergaard
  27. National Institute for Cancer Research, Genoa, Italy.

    • Barbara Parodi
  28. International Prevention Research Institute, Lyon, France.

    • Markus Pasterk
  29. Fundació IMIM, Barcelona, Spain.

    • Acacia Reiche
  30. Thomson Reuters, Toulouse, France.

    • Guillaume Rivalle
  31. Claudius Regaud Institute, Toulouse, France.

    • Philippe Rochaix
  32. Biomed Central, London, UK.

    • Guillaume Susbielle
  33. Latvian Biomedical Research and Study Center, Genome Database of Latvian Population [LGDB], Riga, Latvia.

    • Linda Tarasova
  34. McGill University, Centre of Genomics and Policy, Montreal, Quebec, Canada.

    • Ma'n H Zawati

Consortia

  1. the BRIF workshop group

    A full list of members appears at the end of the paper.

Authors

    Competing interests

    The author declare no competing financial interests.

    Corresponding author

    Correspondence to Anne Cambon-Thomsen.

    About this article

    Publication history

    Published

    DOI

    https://doi.org/10.1038/ng.831

    Further reading

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing